YD Bio YDESW
NASDAQ YDESW
$0.41 -0.06 (-12.77%)
At close: Sep 8, 2026 · 4:00 PM EDT

YD Bio (YDESW) Non-Current Assets (2024 - 2026)

YD Bio's (YDESW) quarterly Non-Current Assets came in at $4.5 million in Q2 2026, up 0.55% year-over-year from $4.4 million in Q2 2025, and up 8.75% quarter-over-quarter from $4.1 million in Q4 2025.

Analysis

YD Bio (YDESW) Non-Current Assets (2024 - 2026) Analysis & Trends

YD Bio (YDESW) has reported Non-Current Assets for 3 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 0.55% year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $16.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.1 million, up 20.99% from the prior year.
  • Non-Current Assets was $4.5 million for Q2 2026 at YD Bio, up from $4.1 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $4.5 million in Q2 2026 and troughed at $3.4 million in Q4 2024.
  • A 3-year average of $4.1 million and a median of $4.3 million in 2025 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets advanced 20.99% in 2025 and advanced 0.55% in 2026, its largest moves.
  • Over 3 years, Non-Current Assets stood at $3.4 million in 2024, then increased by 20.99% to $4.1 million in 2025, then gained by 8.75% to $4.5 million in 2026.
  • The last three Non-Current Assets figures came in at $4.5 million (Q2 2026), $4.1 million (Q4 2025), and $4.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 212.05 Bn 198.06 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 181.76 Bn 178.58 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 132.46 Bn 124.61 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 82.66 Bn 74.67 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 61.56 Bn 56.37 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.69 Bn 49.56 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.46 Bn 30.17 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 30.15 Bn 30.15 Bn 1.16 Mn 564.41 Mn
10 YD Bio 29.02 Mn 26.36 Mn - 4.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.47 Mn
Dec 31, 2025 4.11 Mn
Jun 30, 2025 4.44 Mn
Dec 31, 2024 3.40 Mn